SRPT PDUFA decision: a positive outcome, +73.9%

On September 19, 2016, Sarepta Therapeutics, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +73.9% in the window around the event. It had already run +9.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.